Atezolizumab

ATC L01FF05 · 11 markets · 45 records

Atezolizumab 11 markets · 45 records Forms

AU 8 records · 7 strengths

  • 1,200 mg/20 mLinjectionTECENTRIQ also in GB·US·CN
  • 1,875 mg/15 mLinjectionTECENTRIQ SC also in GB·US·SG
  • 840 mg/14 mLinjectionTECENTRIQ also in GB·US·SG
  • 1,875 mginjectionTECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial also in ES unknown
  • 1,200 mginjectionTECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial also in SG unknown
  • 840 mginjectionTECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial also in ES unknown

Records without a stated strength · 1 TECENTRIQ、TECENTRIQ SC

ES 8 records · 3 strengths

GB 7 records · 4 strengths

HK 4 records · 1 strengths

    Records without a stated strength · 1 TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML、Tecentriq Solution for Subcutaneous Injection

    US 3 records · 3 strengths

    CA 3 records · 2 strengths

    SG 3 records · 3 strengths

    TW 2 records · 1 strengths

      Records without a stated strength · 1 TECENTRIQ、Tecentriq Solution for Subcutaneous Injection、癌自禦 注射劑、癌自禦皮下注射劑 +1

      CN 1 records · 1 strengths

      MX 1 records · 1 strengths

        Records without a stated strength · 1 TECENTRIQ SC

        EU 1 records · 1 strengths

        EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

          Records without a stated strength · 1 TECENTRIQ

          Side-by-side table

          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.